Coumarin-poly(2-oxazoline)s as synergetic and protein-undetected nanovectors for photodynamic therapy
Year: 2024
Type: article
Abstract: Because of the difficult challenges of nanopharmaceutics, the development of a variety of nanovectors is still highly desired. Photodynamic therapy, which uses a photosensitizer to locally produce reactive oxygen species to kill the undesired cells, is a typical example for which encapsulation has been shown to be beneficial. The present work describes the use of coumarin-functionalized polymeric nanovectors based on the self-assembly of amphiphilic poly(2-oxazoline)s. Encapsulation of pheophorbide a, a known PDT photosensitizer, is shown to lead to an increased efficiency compared to the un-encapsulated version. Interestingly, the presence of coumarin both enhances the desired photocytotoxicity and enables the crosslinking of the vectors. Various nanovectors are examined, differing by their size, shape and hydrophilicity. Their behaviour in PDT protocols on HCT-116 cells monolayers is described, the influence of their crosslinking commented. Furthermore, the formation of a protein corona is assessed.
Authors: Diana Heaugwane, Orélia Cerlati, Kedafi Belkhir, Belkacem Tarek Benkhaled, Sylvain Catrouillet, Isabelle Fabing, Catherine Claparols, Marc Vedrenne, Dominique Goudounèche, Bruno Payré, Beatrice Lucia Bona, Alice Tosi, Francesca Baldelli Bombelli, Patricia Vicendo, Vincent Lapinte, Barbara Lonetti, Anne-Françoise Mingotaud, Laure Gibot
Institutions: Centre National de la Recherche Scientifique, Université Toulouse III - Paul Sabatier, Softmat - Chimie des colloïdes, polymères & assemblages complexes, Université de Toulouse, École Nationale Supérieure de Chimie de Montpellier, Université de Montpellier, Institut Charles Gerhardt Montpellier, Unité Matériaux et Transformations, Université Lille 1, Synthèse et Physicochimie de Molécules d'Intérêt Biologique, Institut de Chimie de Toulouse, Politecnico di Milano
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,360
Award: G7632278600
OpenAlex ID: W4396554335
